logo
Lexus is Set To Cut Long-Running Models Within the Next Year

Lexus is Set To Cut Long-Running Models Within the Next Year

Miami Herald01-08-2025
Lexus hasn't initiated a significant change in its catalog in quite some time, but that familiarity is part of what draws people to the brand. The Japanese automaker is getting ready for a major shakeup, however, and is expected to discontinue several models in the coming months.
The long-running Lexus IS and RC will be discontinued late this year, with production of the cars expected to end in November. While that's a bummer, especially the loss of Lexus' excellent V8 in those models, neither car is particularly modern or competitive in its class, with the IS having been on sale since 2014 without a generational update.
Lexus' Japanese website states:
"Thank you for considering our vehicles. Production of the IS 500 / IS 350 / IS 300h (AWD) / IS 300 / RC 350 / RC 300h, and RC 300 will end in November 2025. Sales will end once orders reach the production numbers for November. Depending on when you consider purchasing a vehicle, some packages may no longer be available. Please contact your Lexus dealer for details."
The automaker is expected to release a next-generation IS as soon as 2026. Like the new ES, the IS will likely arrive with more electrified options, but the IS 500's iconic V8 probably won't return. The RC may not get a replacement, but spy shots and rumors point to a new sporty Lexus coupe in the near future.
Lexus also confirmed the RC F Final Edition has sold out with the following message on its Japan site:
"Thank you for your continued patronage of our products. We regret to inform you that the RC F 'Final Edition' has reached its limited number of 200 units and is now sold out. We would like to thank you for your continued patronage of the RC F. The RC 'Final Edition' will be on sale until production ends in November 2025."
Other departures include the LC, which is expected to end production next year, and the UX 300e will end later this year. Reports state that the UX 300h is next, with production ending in March 2026.
Related: Report: Lexus Isn't Cool With Younger Car Buyers
All of this probably makes it sound like Lexus is having a tough time of things, but it's more likely that the automaker has reached a natural stopping point for those models. The new ES sedan was just announced, offering compelling new powertrain options, and the all-electric RZ just received an update with more power and faster charging. That's in addition to the brand's wildly popular gas models, which include the new GX, RX, and others.
Copyright 2025 The Arena Group, Inc. All Rights Reserved.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SoundHound AI (SOUN) Surges 17.34% on Rating, Price Upgrade
SoundHound AI (SOUN) Surges 17.34% on Rating, Price Upgrade

Yahoo

time30 minutes ago

  • Yahoo

SoundHound AI (SOUN) Surges 17.34% on Rating, Price Upgrade

We recently published . SoundHound AI Inc. (NASDAQ:SOUN) is one of the best-performing stocks on Monday. SoundHound AI soared by 17.34 percent on Monday to end at $15.9 apiece as investors took path from an investment firm's upgraded rating for its stock. In a market note, Ladenburg Thalmann raised SoundHound AI Inc. (NASDAQ:SOUN) to 'buy' from 'neutral' previously, alongside a higher price target of $16, as compared with the $9 prior. According to Ladenburg, the upgrade was based on SoundHound AI Inc.'s (NASDAQ:SOUN) increasing deals in the automotive sector that 'can give potential upside opportunity.' 'The penetration in Autos is growing as the company recently announced three major automotive brands in the US have rolled out with SOUN Chat AI embedded. This product drives user engagement and helps establish tech leadership in an increasingly competitive space … Management has pegged in-car commerce opportunity for OEMs at $35 billion annually,' it said. In an updated report, SoundHound AI, Inc. (NASDAQ:SOUN) said it narrowed its non-GAAP net loss in the second quarter of the year by 20 percent to $11.86 million from $14.89 million in the same period last year, but widened its GAAP net loss by 100 percent to $78 million from $37 million year-on-year. Revenues, on the other hand, soared by 217 percent to $42.68 million from only $13.46 million in the same period last year. SoundHound AI, Inc. (NASDAQ:SOUN) raised its full-year revenue growth outlook to a range of $160 million to $178 million, from the previous forecast of $156 million to $177 million. While we acknowledge the potential of SOUN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Cencora Stock: Analyst Estimates & Ratings
Cencora Stock: Analyst Estimates & Ratings

Yahoo

time37 minutes ago

  • Yahoo

Cencora Stock: Analyst Estimates & Ratings

Valued at a market cap of $56 billion, Cencora, Inc. (COR) sources and distributes pharmaceutical products for people and animals. The Conshohocken, Pennsylvania-based company provides essential support, encompassing clinical trial logistics and consulting to packaging, data analytics, and patient adherence programs. This healthcare company has outpaced the broader market over the past 52 weeks. Shares of COR have surged 21.6% over this time frame, while the broader S&P 500 Index ($SPX) has gained 20.6%. Moreover, on a YTD basis, the stock is up 28.7%, compared to SPX's 9.6% return. More News from Barchart Warren Buffett Warns Investing At 'Too-High Purchase Price' Even for 'an Excellent Company' Can Undo a Decade of Smart Investing BitMine Immersion Now Holds 1.15 Million Ethereum Tokens. Should You Buy BMNR Stock Here? Why Archer Aviation's (ACHR) Post-Earnings Tailspin Looks Like a Favorably Mispriced Opportunity Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Zooming in further, COR's outperformance looks even more pronounced when compared to the VanEck Pharmaceutical ETF's (PPH) 11% loss over the past 52 weeks and 3.2% YTD drop. On Aug. 6, Cencora released its Q3 results. Due to growth in both its U.S. and International healthcare solutions segments, the company's overall revenue improved 8.7% year-over-year to $80.7 billion, surpassing consensus estimates by a slight margin. Moreover, its adjusted EPS of $4 advanced 19.8% from the prior-year quarter and came in 5.8% above analyst expectations. Additionally, COR raised its fiscal 2025 adjusted EPS guidance, and now expects it to be between $15.85 and $16. Yet, its shares tumbled 2.9% after the earnings release. For the current fiscal year, ending in September, analysts expect COR's EPS to grow 15.9% year over year to $15.95. The company's earnings surprise history is promising. It surpassed the consensus estimates in each of the last four quarters. Among the 14 analysts covering the stock, the consensus rating is a "Strong Buy' which is based on 11 'Strong Buy,' and three 'Hold' ratings. This configuration is slightly more bullish than three months ago, with 10 analysts suggesting a 'Strong Buy' rating. On Aug. 11, JPMorgan Chase & Co. (JPM) analyst Richard Choe maintained a "Buy" rating on COR and set a price target of $344, implying a 19% potential upside from the current levels. The mean price target of $335 represents a 15.9% premium from COR's current price levels, while the Street-high price target of $355 suggests an ambitious upside potential of 22.8%. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Are Wall Street Analysts Predicting Yum! Brands Stock Will Climb or Sink?
Are Wall Street Analysts Predicting Yum! Brands Stock Will Climb or Sink?

Yahoo

time37 minutes ago

  • Yahoo

Are Wall Street Analysts Predicting Yum! Brands Stock Will Climb or Sink?

Louisville, Kentucky-based Yum! Brands, Inc. (YUM) develops, operates, franchises, and licenses quick service restaurants. Valued at $39.2 billion by market cap, the company prepares, packages, and sells a menu of food items. Shares of this fast-food company have underperformed the broader market over the past year. YUM has gained 4.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.6%. In 2025, YUM's stock rose 5.9%, compared to the SPX's 9.6% rise on a YTD basis. More News from Barchart Warren Buffett Warns Investing At 'Too-High Purchase Price' Even for 'an Excellent Company' Can Undo a Decade of Smart Investing BitMine Immersion Now Holds 1.15 Million Ethereum Tokens. Should You Buy BMNR Stock Here? Why Archer Aviation's (ACHR) Post-Earnings Tailspin Looks Like a Favorably Mispriced Opportunity Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! Narrowing the focus, YUM's underperformance is also apparent compared to the AdvisorShares Restaurant ETF (EATZ). The exchange-traded fund has gained about 16.6% over the past year. However, YUM's gains on a YTD basis outshine the ETF's 1.5% returns over the same time frame. On Aug. 5, YUM shares closed down more than 5% after reporting its Q2 results. Its adjusted EPS of $1.44 did not meet Wall Street expectations of $1.45. The company's revenue was $1.9 billion, matching Wall Street forecasts. For the current fiscal year, ending in December, analysts expect YUM's EPS to grow 9.3% to $5.99 on a diluted basis. The company's earnings surprise history is mixed. It beat the consensus estimate in two of the last four quarters while missing the forecast on two other occasions. Among the 27 analysts covering YUM stock, the consensus is a 'Moderate Buy.' That's based on nine 'Strong Buy' ratings, and 18 'Holds.' This configuration is more bullish than two months ago, with eight analysts suggesting a 'Strong Buy.' On Aug. 6, Gregory Francfort from Guggenheim reiterated a 'Buy' rating on YUM with a price target of $167, implying a potential upside of 17.5% from current levels. The mean price target of $160.65 represents a 13.1% premium to YUM's current price levels. The Street-high price target of $185 suggests an ambitious upside potential of 30.2%. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store